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SUMMARY
A 56-year-old man presented with weight loss, articular
pain and minor neurological symptoms progressing over
1 month. Neurosonological evaluation suggested
occlusion in intracranial segments of the left vertebral
artery (VA) and of both internal carotid arteries (ICA)
and hypoechoic halo sign in both superﬁcial temporal
arteries. The diagnosis of giant cell arteritis was
supported by inﬂammatory markers and conﬁrmed by
biopsy. Despite early steroid initiation, he manifested
ﬂuctuant vascular deﬁcits and became lethargic. Brain
MRI indicated watershed infarcts and intracranial
dissections of left VA and both ICA. The patient was
stabilised with the association of prednisolone 2 mg/kg,
methotrexate and oral anticoagulation. Since then he
has been neurologically asymptomatic and control
imaging showed only residual intracranial left VA
stenosis, with no signs of temporal artery inﬂammation
or new vascular lesions. This is to the best of our
knowledge, the ﬁrst reported clinical case with such an
extensive intracranial involvement with multiple
dissections.
BACKGROUND
Giant cell arteritis (GCA) is a chronic systemic
granulomatous vasculitis typically occurring in
patients over the age of 50, and involving large-
sized and medium-sized arteries containing an
elastic lamina.1–7
Superﬁcial temporal arteries are the most com-
monly affected in this disease. The ophthalmic,
posterior ciliary and vertebral arteries are also often
involved. On the other hand, intracranial arteries
are generally not affected.1 6
An arterial inﬂammatory process leads to intimal
thickening, luminal irregularities, stenosis, and
ultimately occlusion, which can provoke infarction
or borderzone hypoperfusion. Occlusion or distal
embolisation can also follow in situ thrombosis.4 5
GCA can present with a variety of symptoms,
including neurological symptoms such as headache,
jaw claudication, visual symptoms (diplopia,
ﬂimmer scotoma, amaurosis fugax) or cerebrovascu-
lar events (transient ischaemic attack and stroke in
approximately 2–4% of patients with GCA).1–4 7 8
These events occur in the vertebrobasilar territory
more frequently than in general population (50–
75% vs 15–20%) and are secondary to extracranial
stenosis and occlusion of internal carotid and/or,
more likely, vertebral arteries.2–4 7 8
Intracranial arteries are usually spared in GCA
and we could not ﬁnd reports of other cases of
intracranial dissections as a presentation of this
disease. This case report intends to call attention to
the importance of keeping in mind that GCA may
present in numerous and sometimes never before
reported ways. This may lead to a wrong or late
diagnosis, which can inﬂuence treatment and
prognosis.
CASE PRESENTATION
A 56-year-old man presented with apathy, psycho-
motor slowing, anorexia, marked weight loss, large
articular pain with an inﬂammatory rhythm
(mainly around the shoulder girdle) progressing
over 1 month. He also presented with gait impair-
ment and constant frontotemporal headache
without dysautonomia, nausea or vomit and unre-
lated to orthostatism but disturbing night sleep.
Abnormal ﬁndings on initial neurological exam-
ination included psychomotor slowing with delayed
responses, left central facial palsy, a mild spastic tet-
raparesis and tenderness of the temporal arteries.
Vital signs were normal.
Analytic workup showed mild normocytic nor-
mochromic anaemia (haemoglobin 12.8 g/dL), mild
thrombocytosis (422×109/L) and increased values
of C reactive protein (CRP) (8.89 mg/dL). Head
CT was unremarkable. Moreover, cerebrospinal
ﬂuid analysis showed mild pleocytosis (a white cell
count of 12 cells/mL, mostly mononuclear) with
normal protein and glucose levels. Infectious, auto-
immune, neoplastic and hormonal workup were
unremarkable.
Initial cervical ultrasound indicated mild athero-
sclerotic pathology and high-resistance ﬂow in cer-
vical segments of the left vertebral artery (VA) with
occlusive ﬂow in V3 segment and inversion of its
V4 segment with no other changes in transcranial
arteries.
During the ﬁrst few days, the patient showed
rapid neurological deterioration with progressive
impairment of awareness (Glasgow Coma
Scale=12). Control ultrasonography at day 3
revealed a high resistance ﬂow in the extracranial
right internal carotid artery (ICA) maintaining a
high-resistance ﬂow in the left VA and also a bilat-
eral hypoechoic halo sign in the superﬁcial tem-
poral arteries (more pronounced on the left side;
ﬁgure 1). Both ophthalmic arteries were normal. At
this time, superﬁcial temporal artery biopsy was
consistent with the diagnosis of GCA (ﬁgure 2).
Despite steroid initiation at day 4 (prednisolone
80 mg/day orally) there was a clinical deterioration
with progressive impairment of mental status and
several transient episodes of focal deﬁcits (aphasia
and right hemiparesis) as well as a laboratory
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worsening with higher platelet count, CRP and erythrocyte sedi-
mentation rate (ESR) values (519×109/L, 18.89 mg/dL and
83 mm/h, respectively).
Brain MRI showed multiple recent watershed infarctions and
intracranial dissections of the left VA and of both ICA (ﬁgure 3).
The third ultrasonographic study (7 days after admission) main-
tained previous ﬁndings.
The patient was started on warfarin, 15 mg weekly of metho-
trexate (MTX) and increasing dosage of prednisolone up to
120 mg (2 mg/kg) daily in order to achieve clinical stability.
OUTCOME AND FOLLOW-UP
Two months later, a follow-up neurosonological examination
and MRI showed residual intracranial left VA stenosis (in the
beginning of V4 segment), complete recanalisation of ICAs with
no signs of temporal artery inﬂammation or new vascular
lesions.
Three years after the initial presentation, this patient is neuro-
logically asymptomatic and has an ESR value of 12 mm/h. As a
complication of chronic steroid therapy, he had an aseptic
necrosis of the left femoral head that required prosthetic hip
replacement. After several unsuccessful attempts of steroid with-
drawal he is still on 20 mg daily of prednisolone plus 8 mg
weekly of MTX.
DISCUSSION
It is believed that the usual sparing of intracranial arteries in
GCA is due to the fact that this disease involves an autoimmune
reaction against arterial elastic tissue, which is absent or reduced
within about 5 mm entering the dura.3 8
Analytic workup typically shows changes seen in systemic vas-
culitis, such as increased ESR and CRP values in >90% of
patients. Furthermore, in between one-third and half of all
patients, it can also be found as mild normocytic, normochro-
mic anaemia, thrombocytosis, liver enzyme abnormalities or low
complement.1 2
Our patient presented with systemic symptoms, headache and
neurological deﬁcits, which are all usually seen in patients with
GCA. The diagnosis of this condition was also based on labora-
tory and imaging ﬁndings and conﬁrmed through temporal
artery biopsy. The presence of watershed infarctions secondary
to dissections of the left VA and both ICA intracranially was
demonstrated by MRI and ultrasonography. Other causes of
arterial dissections were ruled out, such as infections and con-
nective tissue disorders.
Among non-invasive imaging studies, ultrasonographic evalu-
ation of the superﬁcial temporal arteries has been emerging as
an important diagnostic tool.1 8 In fact, neurosonology can play
a crucial role in demonstrating cerebral involvement and, more
importantly, in the follow-up of these patients.2 An irregular
hypoechoic circumferential wall thickening around the lumen of
the superﬁcial temporal arteries, denominated ‘halo sign’, is
typical and usually disappears after 2–3 weeks of treatment.1
Arida et al9 demonstrated that in the hands of experienced
ultrasonographers, a unilateral halo sign has a speciﬁcity of 91%
(95% CI 0.88 to 0.94) and a sensitivity of 68% (95% CI 0.61
to 0.74) for GCA.9 The same authors reported that the presence
of a bilateral halo sign improves speciﬁcity to 100%, but
reduces the sensitivity to 43%.9
MRI can also reveal signs of inﬂammation of the superﬁcial
temporal arteries.10 Bley et al11 examined 21 patients for GCA,
showing that contrast-enhanced MRI had a diagnostic sensitivity
of 88.9% and a speciﬁcity of 91.7% when compared with the
American College of Rheumatology criteria; the diagnostic sen-
sitivity was 100% and the speciﬁcity 80% when compared with
biopsy of the temporal artery.11
This clinical case also presents with some interesting details
regarding the treatment. Clinical guidelines universally recom-
mend rapid initiation of corticosteroid treatment and biopsy of
the temporal artery as soon as possible.12 However, there is
currently limited data regarding the effectiveness of glucocorti-
costeroid sparing therapies in refractory GCA, namely metho-
trexate and azathioprine.7 In our case, clinical and imagiological
stability was only achieved through the institution of high doses
of prednisolone in association with MTX and oral
anticoagulation.
Antithrombotic medication in GCA is also recommended if
there is no contraindication.1 5 8 However, in intracranial dissec-
tions, this choice is controversial and no clear evidence-based
recommendation has been issued. In our case, due to repeated
transient ischaemic attacks with presumed embolic mechanism
while on antiplatelet therapy, we decided to treat the patient
with warfarin. Bearing in mind that the patient was on concomi-
tant steroid therapy, it is nevertheless remarkable that there were
no further ischaemic events reported.
Another unusual detail is the fact that although the majority
of patients are able to discontinue corticotherapy after 1–2
years,1 our patient has still not been able to do so, as CRP and
ESR values tend to rise every time tapering is tried. However,
there are reports of some patients with a relapsing chronic
Figure 1 Superﬁcial temporal artery
ultrasonography on day 3—hypoechoic
halo sign in transverse (A) and
longitudinal (B) view of the left
superﬁcial temporal artery.
Figure 2 Superﬁcial temporal artery
biopsy. (A) H&E stain ×50, vessel with
reduced lumen due to intimal
thickening; inﬂammatory inﬁltrate;
(B) H&E stain ×400, inﬂammatory
inﬁltrate and giant cells (arrows);
(C) elastic van Gieson stain ×400,
giant cell (arrow) and fragmentation of
the elastic lamina.
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course of disease, with a need of low-dose corticosteroids
indeﬁnite treatment, which implies signiﬁcant risk of steroid-
associated side effects.1
This is to our knowledge, the ﬁrst reported clinical case with
such an extensive involvement of intracranial vasculature.
Learning points
▸ Giant cell arteritis (GCA) may very rarely present with
involvement of intracranial arteries.
▸ Multiple intracranial dissections are a possible presentation
of GCA.
▸ Neurosonology plays a key role in the diagnosis and
follow-up of patients with GCA.
▸ Extensive intracranial involvement in GCA appears to require
long-term steroid therapy.
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Figure 3 Subacute brain MRI and MR angiography. (A) Diffusion-weighted imaging showing internal borderzone infarcts bilaterally. (B and C)
T1-weighted fat-suppressed images. Intramural haematoma of both internal carotid arteries (B) and left vertebral artery (C) are visible. (D and E) MR
angiography with typical pencil-like occlusion of internal carotid arteries and the left vertebral artery.
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